Wells Fargo’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.61M | Sell |
111,070
-228,356
| -67% | -$3.27M | ﹤0.01% | 3433 |
|
|
2025
Q4 | $4.83M | Buy |
339,426
+146,923
| +76% | +$1.44M | ﹤0.01% | 2711 |
|
|
2025
Q3 | $1.52M | Buy |
192,503
+30,924
| +19% | +$220K | ﹤0.01% | 3514 |
|
|
2025
Q2 | $926K | Sell |
161,579
-3,139
| -2% | -$20.3K | ﹤0.01% | 3737 |
|
|
2025
Q1 | $1.34M | Sell |
164,718
-274,753
| -63% | -$2.54M | ﹤0.01% | 3464 |
|
|
2024
Q4 | $4.14M | Buy |
439,471
+24,882
| +6% | +$259K | ﹤0.01% | 2584 |
|
|
2024
Q3 | $4.43M | Sell |
414,589
-196,197
| -32% | -$2.14M | ﹤0.01% | 2435 |
|
|
2024
Q2 | $6.06M | Buy |
610,786
+239
| +0% | +$2.45K | ﹤0.01% | 2116 |
|
|
2024
Q1 | $7.19M | Buy |
610,547
+39,591
| +7% | +$506K | ﹤0.01% | 2009 |
|
|
2023
Q4 | $8.1M | Sell |
570,956
-126,245
| -18% | -$1.43M | ﹤0.01% | 1861 |
|
|
2023
Q3 | $8.48M | Sell |
697,201
-50,351
| -7% | -$650K | ﹤0.01% | 1682 |
|
|
2023
Q2 | $9.39M | Buy |
747,552
+55,739
| +8% | +$661K | ﹤0.01% | 1642 |
|
|
2023
Q1 | $7.67M | Buy |
691,813
+147,422
| +27% | +$1.82M | ﹤0.01% | 1787 |
|
|
2022
Q4 | $6.65M | Buy |
544,391
+107,659
| +25% | +$1.21M | ﹤0.01% | 1856 |
|
|
2022
Q3 | $4.56M | Sell |
436,732
-33,774
| -7% | -$376K | ﹤0.01% | 2067 |
|
|
2022
Q2 | $5.05M | Sell |
470,506
-146,917
| -24% | -$1.21M | ﹤0.01% | 2099 |
|
|
2022
Q1 | $5.85M | Sell |
617,423
-31,885
| -5% | -$299K | ﹤0.01% | 2315 |
|
|
2021
Q4 | $7.5M | Sell |
649,308
-101,584
| -14% | -$1.13M | ﹤0.01% | 2132 |
|
|
2021
Q3 | $7.17M | Buy |
750,892
+222,725
| +42% | +$2.28M | ﹤0.01% | 2511 |
|
|
2021
Q2 | $5.09M | Sell |
528,167
-140,754
| -21% | -$1.37M | ﹤0.01% | 2855 |
|
|
2021
Q1 | $6.61M | Buy |
668,921
+274,391
| +70% | +$4.25M | ﹤0.01% | 2566 |
|
|
2020
Q4 | $9.11M | Buy |
394,530
+153,935
| +64% | +$3.15M | ﹤0.01% | 2158 |
|
|
2020
Q3 | $3.4M | Sell |
240,595
-60,939
| -20% | -$888K | ﹤0.01% | 2860 |
|
|
2020
Q2 | $4.55M | Buy |
301,534
+46,040
| +18% | +$561K | ﹤0.01% | 2548 |
|
|
2020
Q1 | $2.36M | Sell |
255,494
-45,889
| -15% | -$436K | ﹤0.01% | 2850 |
|
|
2019
Q4 | $2.94M | Buy |
301,383
+20,715
| +7% | +$190K | ﹤0.01% | 3019 |
|
|
2019
Q3 | $2.25M | Buy |
280,668
+27,972
| +11% | +$304K | ﹤0.01% | 3230 |
|
|
2019
Q2 | $3.15M | Buy |
252,696
+8,661
| +4% | +$110K | ﹤0.01% | 2962 |
|
|
2019
Q1 | $3.32M | Buy |
244,035
+6,172
| +3% | +$75.4K | ﹤0.01% | 2931 |
|
|
2018
Q4 | $2.28M | Sell |
237,863
-349,711
| -60% | -$3.84M | ﹤0.01% | 3150 |
|
|
2018
Q3 | $7.11M | Sell |
587,574
-56,318
| -9% | -$788K | ﹤0.01% | 2348 |
|
|
2018
Q2 | $10.1M | Sell |
643,892
-2,179,960
| -77% | -$33M | ﹤0.01% | 2073 |
|
|
2018
Q1 | $42.5M | Buy |
2,823,852
+2,051,947
| +266% | +$31.2M | 0.01% | 990 |
|
|
2017
Q4 | $11.1M | Buy |
771,905
+574,101
| +290% | +$7.89M | ﹤0.01% | 1921 |
|
|
2017
Q3 | $2.98M | Buy |
197,804
+78,142
| +65% | +$1.03M | ﹤0.01% | 2957 |
|
|
2017
Q2 | $1.21M | Sell |
119,662
-33,811
| -22% | -$272K | ﹤0.01% | 3598 |
|
|
2017
Q1 | $1.09M | Buy |
153,473
+28,287
| +23% | +$179K | ﹤0.01% | 3681 |
|
|
2016
Q4 | $622K | Buy |
125,186
+58,563
| +88% | +$405K | ﹤0.01% | 4048 |
|
|
2016
Q3 | $493K | Buy |
66,623
+24,343
| +58% | +$164K | ﹤0.01% | 3956 |
|
|
2016
Q2 | $231K | Sell |
42,280
-7,883
| -16% | -$55.1K | ﹤0.01% | 4326 |
|
|
2016
Q1 | $424K | Buy |
50,163
+7,746
| +18% | +$54.9K | ﹤0.01% | 3964 |
|
|
2015
Q4 | $412K | Sell |
42,417
-7,797
| -16% | -$70.3K | ﹤0.01% | 4028 |
|
|
2015
Q3 | $703K | Buy |
50,214
+9,392
| +23% | +$147K | ﹤0.01% | 3733 |
|
|
2015
Q2 | $579K | Sell |
40,822
-3,628
| -8% | -$43.6K | ﹤0.01% | 3984 |
|
|
2015
Q1 | $484K | Buy |
44,450
+15,481
| +53% | +$136K | ﹤0.01% | 3968 |
|
|
2014
Q4 | $241K | Buy |
+28,969
| New | +$199K | ﹤0.01% | 4329 |
|
|
2013
Q3 | – | Sell |
-3,836
| Closed | -$9K | – | 5707 |
|
|
2013
Q2 | $9K | Buy |
+3,836
| New | +$11.8K | ﹤0.01% | 5082 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Wells Fargo's FOLD Position: Q1 2026 in Review
Wells Fargo reduced its Amicus Therapeutics (FOLD) stake by 67% in Q1 2026, selling an estimated $3.27M and leaving 111,070 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3433.
Wells Fargo first reported a position in FOLD in Q2 2013 and has held it in 47 quarters since. The position peaked at $42.5M in Q1 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Wells Fargo held 111,070 shares of Amicus Therapeutics worth $1.61M as of Q1 2026.
- Wells Fargo sold 228,356 Amicus Therapeutics shares in Q1 2026, an estimated $3.27M.
- Amicus Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3433 holding.
- Wells Fargo first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 47 quarters since.
- Wells Fargo's Amicus Therapeutics position peaked at $42.5M in Q1 2018.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.